Nuvo Pharmaceuticals Inc NRIFF

Primary Symbol: MRVFF

Healthcare Drug Manufacturers - Specialty & Generic

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.

OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc

Bullboard Posts

Comment by daydream1on Apr 21, 2011 10:18am

310 Views

Post# 18468676

RE: 150 million annualized?

Curbe your enthusiasm there.

From page 3 of COV quarterly

" branded pharmaceuticals, sales of our new EXALGO® and PENNSAID® products did not offset a significant decline for our older brands, which stemmed from competition from generics. "

So Pennsaid is not selling all that much. While you are all blinded by Zars's aquisistion and "the deal" and "Pennsaid sale" You seem to have lost sight of WF10. Nuvo has put a lot of money in this and have yet to generate any interest. I am not confident that WF10 results will show any significate effect. That is what investors are waiting for now, to hear about what will happen with WF10. Is it a dud, or can they sale WF10 to a bib pharma and focus on pain treatment.

That is why this stock price is not moving so much... until the results come out.

Goodluck
D.